Dr. Mirza on Hematuria and a Bladder Cancer Diagnosis
Moben Mirza, MD, assistant professor of urology at the University of Kansas Medical Center, discusses a study presented at the 2014 AUA Annual Meeting that evaluated gender and race variation in the workup of hematuria.
Moben Mirza, MD, assistant professor of urology at the University of Kansas Medical Center, discusses a study presented at the 2014 AUA Annual Meeting that evaluated gender and race variation in the workup of hematuria.
Mirza says this study has application in the field of oncology as the classical presentation for bladder cancer includes painless, gross hematuria. There have been recent discussions and education efforts in the urological community regarding whether or not urologists must see these patients with blood in their urine.
This study showed that an alarming rate (about 60%) of patients with hematuria never received a workup. In addition, the majority of patients over 50 years old presenting with gross hematuria will have a diagnosable problem that is most likely bladder cancer.
<<<
